IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-70

  1. 343 Posts.
    lightbulb Created with Sketch. 23
    Need to refrain from having a whinge here and I don’t think charts will tell us anything. neither will daily checks of SP.
    there’s not much more to say about IXC at the moment. My families rather Large holding remains and will not be going anywhere.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.